SCHEMBL29655185

SCHEMBL29655185

COCCOc1ccccc1-c1ccc(N)c(N)c1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AR P10275 2/20 0.53
ADRB2 P07550 3/20 0.49
TP53 P04637 1/20 0.44
MAPK1 P28482 1/20 0.44
RAB9A P51151 1/20 0.44
KDM4E B2RXH2 4/20 0.44
ALOX5AP P20292 3/20 0.43
FEN1 P39748 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
HTR7 P34969 1/20 0.42
REN P00797 1/20 0.41
ADRB1 P08588 1/20 0.41
PTPRC P08575 1/20 0.41
DHFR P00374 1/20 0.41
GAA P10253 1/20 0.41
MAP4K4 O95819 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29655044 0.82 MAPT (0.50) ARADRB2MAPK1RAB9AKDM4E
SCHEMBL29655117 0.80 PTPRC (0.56) ARALOX5APFEN1HTR7PTPRC
SCHEMBL29655234 0.80 PTPRC (0.56) ARALOX5APFEN1HTR7PTPRC
SCHEMBL5953394 0.80 PTPRC (0.56) ARALOX5APFEN1HTR7PTPRC
SCHEMBL10528636 0.79 ADRB2 (0.73) ADRB2TP53MAPK1RAB9AKDM4E
SCHEMBL478309 0.78 HTR7 (0.56) ARADRB2TP53MAPK1RAB9A
SCHEMBL2572079 0.77 ADRB2 (0.54) ARADRB2TP53MAPK1RAB9A
SCHEMBL9073879 0.75 ALDH1A1 (0.63) ARTP53MAPK1KDM4EL3MBTL1
SCHEMBL29684634 0.75 CYP1A2 (0.66) ADRB2TP53KDM4EL3MBTL1GAA
SCHEMBL1029928 0.75 CYP1A2 (0.66) ADRB2TP53KDM4EL3MBTL1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843874-B Phthalazine derivatives useful as inhibitors of PARP1, PARP2 and/or tubulin for the treatment of cancer 加利福尼亚大学董事会 2022-05-27 CN disclosed